{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:39:13Z","timestamp":1767184753540,"version":"build-2238731810"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,3,1]]},"DOI":"10.1542\/pir.23.3.85","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:21:10Z","timestamp":1639135270000},"page":"85-94","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Evaluation of Substance Abuse"],"prefix":"10.1542","volume":"23","author":[{"given":"Paritosh","family":"Kaul","sequence":"first","affiliation":[{"name":"Postdoctoral Fellow in Adolescent Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Coupey","sequence":"additional","affiliation":[{"name":"Professor of Pediatrics, Associate Director, Adolescent Medicine, Children\u2019s Hospital at Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2002,3,1]]},"reference":[{"key":"2021121007032829500_R1","doi-asserted-by":"crossref","unstructured":"Alcohol, Drug Abuse, and Mental Health Administration. Cannabinoid receptor gene cloned. JAMA.\u20081990; 264: 1389","DOI":"10.1001\/jama.1990.03450110035006"},{"key":"2021121007032829500_R2","unstructured":"American Academy of Pediatrics Committee on Substance Abuse. Testing for drugs of abuse in children and adolescents. Pediatrics.\u20081998; 98: 305\u2013307"},{"key":"2021121007032829500_R3","unstructured":"Centers for Disease Control and Prevention. Youth risk behavior surveillance\u2014United States, 1999. Morbid Mortal Wkly Rep MMWR.\u20082000; 49(SS 05): 1\u201396"},{"key":"2021121007032829500_R4","doi-asserted-by":"crossref","unstructured":"Coupey SM. Barbiturates. Pediatr Rev.\u20081997; 18: 260\u2013265","DOI":"10.1542\/pir.18-8-260"},{"key":"2021121007032829500_R5","doi-asserted-by":"crossref","unstructured":"Coupey SM. Interviewing adolescents. Pediatr Clin North Am.\u20081997; 44: 1349\u20131364","DOI":"10.1016\/S0031-3955(05)70563-0"},{"key":"2021121007032829500_R6","doi-asserted-by":"crossref","unstructured":"Crowley TJ, MacDonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend.\u20081998; 50: 27\u201337","DOI":"10.1016\/S0376-8716(98)00003-9"},{"key":"2021121007032829500_R7","doi-asserted-by":"crossref","unstructured":"Duffy A, Milin R. Case study: withdrawal syndrome in adolescent chronic cannabis users. J Am Acad Child Adolesc Psychiat.\u20081996; 35: 1618\u20131621","DOI":"10.1097\/00004583-199612000-00013"},{"key":"2021121007032829500_R8","doi-asserted-by":"crossref","unstructured":"Farrar HC, Kearns GL. Cocaine: clinical pharmacology and toxicology. J Pediatr.\u20081989; 115: 665\u2013675","DOI":"10.1016\/S0022-3476(89)80640-7"},{"key":"2021121007032829500_R9","doi-asserted-by":"crossref","unstructured":"Gittelman R, Mannuzza S, Shenker R, Bonagura N. Hyperactive boys almost grown up. Arch Gen Psychiatry.\u20081985; 42: 937\u2013947","DOI":"10.1001\/archpsyc.1985.01790330017002"},{"key":"2021121007032829500_R10","doi-asserted-by":"crossref","unstructured":"Harrison PA, Fulkerson JA, Beebe TJ. Multiple substance use among adolescent physical and sexual abuse victims. Child Abuse Neglect.\u20081997; 21: 529\u2013539","DOI":"10.1016\/S0145-2134(97)00013-6"},{"key":"2021121007032829500_R11","unstructured":"Johnson LD, O\u2019Malley PM, Bachman JG. Monitoring the Future Study. Washington, DC: United States Department of Health and Human Services; 2000. Available at www.monitoringthefuture.org"},{"key":"2021121007032829500_R12","doi-asserted-by":"crossref","unstructured":"Kandel DB, Johnson JG, Bird HR, et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA study. J Am Acad Child Adolesc Psychiatry.\u20081999; 38: 693\u2013696","DOI":"10.1097\/00004583-199906000-00016"},{"key":"2021121007032829500_R13","doi-asserted-by":"crossref","unstructured":"Neumark YD, Delva J, Anthony JC. The epidemiology of adolescent inhalant involvement. Arch Pediatr Adolesc Med.\u20081998; 152: 781\u2013786","DOI":"10.1001\/archpedi.152.8.781"},{"key":"2021121007032829500_R14","doi-asserted-by":"crossref","unstructured":"Pentel P. Toxicity of over-the-counter stimulants. JAMA.\u20081984; 252: 1898\u20131903","DOI":"10.1001\/jama.252.14.1898"},{"key":"2021121007032829500_R15","doi-asserted-by":"crossref","unstructured":"Resnick MD, Bearman PS, Blum RW, et al. Protecting adolescents from harm: findings from the national longitudinal study on adolescent health. JAMA.\u20081997; 278: 823\u2013832","DOI":"10.1001\/jama.278.10.823"},{"key":"2021121007032829500_R16","doi-asserted-by":"crossref","unstructured":"Rickert VI, Wiemann CM, Berenson AB. Prevalence, patterns, and correlates of voluntary flunitrazepam use. Pediatrics.\u20081999; 103: e6\u2013e9. Available at http:\/\/www.pediatrics.org\/cgi\/content\/full\/103\/1\/e6","DOI":"10.1542\/peds.103.1.e6"},{"key":"2021121007032829500_R17","unstructured":"Schwartz R. Testing for drugs of abuse: controversies and techniques. Adolesc Med.\u20081993; 4: 353\u2013370"},{"key":"2021121007032829500_R18","doi-asserted-by":"crossref","unstructured":"Schwartz RH. LSD: its rise, fall, and renewed popularity among high school students. Pediatr Clin North Am.\u20081995; 42: 403\u2013413","DOI":"10.1016\/S0031-3955(16)38954-4"},{"key":"2021121007032829500_R19","doi-asserted-by":"crossref","unstructured":"Steinberg L, Fletcher A, Darling N. Parental monitoring and peer influence on adolescent substance use. Pediatrics.\u20081994; 93: 1060\u20131064","DOI":"10.1542\/peds.93.6.1060"},{"key":"2021121007032829500_R20","unstructured":"Strasburger VC, Donnerstein E. Children, adolescents, and the media in the 21st century: Adolesc Med.\u20082000; 11: 51\u201368"},{"key":"2021121007032829500_R21","doi-asserted-by":"crossref","unstructured":"Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science.\u20081997; 276: 2048\u20132050","DOI":"10.1126\/science.276.5321.2048"},{"key":"2021121007032829500_R22","doi-asserted-by":"crossref","unstructured":"Weisbeck GA, Schuckit MA, Kalmijn JA, et al. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction.\u20081996; 91: 1469\u20131478","DOI":"10.1046\/j.1360-0443.1996.911014696.x"}],"container-title":["Pediatrics In Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/23\/3\/85\/993228\/px0302000085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article-pdf\/23\/3\/85\/993228\/px0302000085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T17:38:00Z","timestamp":1673977080000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatricsinreview\/article\/23\/3\/85\/65075\/Clinical-Evaluation-of-Substance-Abuse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3,1]]},"references-count":22,"aliases":["10.1542\/pir.23-3-85"],"journal-issue":{"issue":"3","published-online":{"date-parts":[[2002,3,1]]},"published-print":{"date-parts":[[2002,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/pir.23.3.85","relation":{},"ISSN":["0191-9601","1526-3347"],"issn-type":[{"value":"0191-9601","type":"print"},{"value":"1526-3347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3,1]]}}}